Belatacept in Solid Organ Transplantation: Current Kidney Applications, Future Perspectives in Other Organs, and Clinical Implications.

Pharmaceuticals (Basel) · 2026 · PMC12943736 · PMID 41754737

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although belatacept-treated patients reported fewer side-effect-related symptoms than cyclosporine-treated patients, differences did not reach statistical significance, despite a consistent trend favoring belatacept.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.